Back to Trades
Grant4
Anika Therapeutics, Inc.
ANIK
Total Value
$84.4K
Company Information
- Company Name
- Anika Therapeutics, Inc.
- Ticker Symbol
- ANIK
- CIK
- 0000898437
Insider Information
- Role
- Insider
- Location
- BEDFORD, MA
Filing Details
- Filing Date
- Mar 17, 2026
- Transaction Date
- Mar 14, 2026
- Accession Number
- 0001193125-26-111502
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 14, 2026 | Common Stock | 12,824 | — | Exercise | — |
| Mar 14, 2026 | Common Stock | 6,412 | — | Grant/Award | — |
| Mar 14, 2026 | Common Stock | 5,944 | $14.20 | Tax Withholding | $84.4K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 14, 2026 | Derivative | 12,824 | — | Exercise | — |
Footnotes
- (F1)Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.
- (F2)On March 14, 2025, the Reporting Person was granted 19,236 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award.
- (F3)Reflects an aggregate of 5,944 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026.
- (F4)On March 14, 2025, the Reporting Person was granted 38,473 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.